These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3038818)

  • 21. Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide.
    Viljanen P; Käyhty H; Vaara M; Vaara T
    Can J Microbiol; 1986 Jan; 32(1):66-9. PubMed ID: 3008971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of K88ab-mediated haemagglutination by polymyxin B nonapeptide.
    Matranga AM; Moore B; Bennett PM; Chopra I
    J Antimicrob Chemother; 1991 Nov; 28(5):655-62. PubMed ID: 1685733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting lipopolysaccharides by the nontoxic polymyxin B nonapeptide sensitizes resistant Escherichia coli to the bactericidal effect of human neutrophils.
    Rose F; Heuer KU; Sibelius U; Hombach-Klonisch S; Kiss L; Seeger W; Grimminger F
    J Infect Dis; 2000 Jul; 182(1):191-9. PubMed ID: 10882597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temperature dependence of bactericidal action of polymyxin B.
    Hodate K; Bito Y
    Microbiol Immunol; 1982; 26(8):737-40. PubMed ID: 6294487
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of polymyxin B sulfate and polymyxin B nonapeptide on growth and permeability of the yeast Saccharomyces cerevisiae.
    Boguslawski G
    Mol Gen Genet; 1985; 199(3):401-5. PubMed ID: 2993791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymyxin B octapeptide and polymyxin B heptapeptide are potent outer membrane permeability-increasing agents.
    Kimura Y; Matsunaga H; Vaara M
    J Antibiot (Tokyo); 1992 May; 45(5):742-9. PubMed ID: 1624376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for increasing electroporation competence of Gram-negative clinical isolates by polymyxin B nonapeptide.
    Qin J; Hong Y; Pullela K; Morona R; Henderson IR; Totsika M
    Sci Rep; 2022 Jul; 12(1):11629. PubMed ID: 35804085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lethal zygosis in recombination-deficient mutants of Escherichia coli.
    Nestmann ER
    Can J Genet Cytol; 1979 Jun; 21(2):213-21. PubMed ID: 383244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyxin B nonapeptide inhibits mating in Saccharomyces cerevisiae.
    Boguslawski G
    Antimicrob Agents Chemother; 1986 Feb; 29(2):330-2. PubMed ID: 3013083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of antibacterial spectrum of xanthorrhizol against Gram-negatives in combination with PMBN and food-grade antimicrobials.
    Kim MS; Kim HR; Kim H; Choi SK; Kim CH; Hwang JK; Park SH
    J Microbiol; 2019 May; 57(5):405-412. PubMed ID: 30796747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic recombination by spheroplast fusion in Escherichia coli K12.
    Reina S; Debbia EA; Schito GC
    Cytobios; 1993; 76(305):91-5. PubMed ID: 8293682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane.
    Viljanen P; Koski P; Vaara M
    Infect Immun; 1988 Sep; 56(9):2324-9. PubMed ID: 3137167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the nature of the action of polyamines on Escherichia coli conjugation.
    Kwiatkowski Z; Heleszko H
    Acta Microbiol Pol A; 1969; 1(2):101-8. PubMed ID: 4897595
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid and lipopolysaccharide composition of Escherichia coli surface-altered mutants selected for resistance to levallorphan, tetracaine, and polymyxin.
    Dame JB; Shapiro BM
    J Bacteriol; 1979 Feb; 137(2):1043-7. PubMed ID: 217864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide.
    Duwe AK; Rupar CA; Horsman GB; Vas SI
    Antimicrob Agents Chemother; 1986 Aug; 30(2):340-1. PubMed ID: 3021053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of polymyxin B on ion permeability of bacterial membranes].
    Kapitanova NG; Korepanova EA; Gariaev AA; Frolov VN; Antonov VF
    Biofizika; 1981; 26(6):1100-2. PubMed ID: 6274432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increases in permeability of Escherichia coli outer membrane induced by polycations.
    Katsu T; Yoshimura S; Fujita Y
    FEBS Lett; 1984 Jan; 166(1):175-8. PubMed ID: 6363126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mathematical study of the sensitivity curves of Escherichia coli exposed to polymyxins].
    Peyret M; Carret G; Carre C; Fardel G; Flandrois JP
    Pathol Biol (Paris); 1990 May; 38(5):441-5. PubMed ID: 2164182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of specific growth rate and nutrient-limitation upon the sensitivity of Escherichia coli towards polymyxin B.
    Wright NE; Gilbert P
    J Antimicrob Chemother; 1987 Sep; 20(3):303-12. PubMed ID: 2824423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.